Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection
Authors:
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Chemistry & Biology
- Vol. 22 (8) , 1074-1086
Abstract
No abstract availableKeywords
Funding Information
- NSF Graduate Research Fellowship (DGE-0822)
- Bill and Melinda Gates Foundation Grand Challenges Explorations Award
- Linda Pechenik Montague Investigator Award
- NIH (DP2OD002177, R01GM099836, R21HD074510)
This publication has 50 references indexed in Scilit:
- Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and diseaseCellular and Molecular Life Sciences, 2014
- The elusive middle domain of Hsp104 and ClpB: Location and functionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendencyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Applying Hsp104 to protein-misfolding disordersThis paper is one of a selection of papers published in this special issue entitled 8th International Conference on AAA Proteins and has undergone the Journal's usual peer review process.Biochemistry and Cell Biology, 2010
- Prion proteostasisPrion, 2008
- Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prionsThe EMBO Journal, 2008
- Hsp104: A Weapon to Combat Diverse Neurodegenerative DisordersNeurosignals, 2007
- Semen-Derived Amyloid Fibrils Drastically Enhance HIV InfectionCell, 2007
- Navigating the ClpB channel to solutionNature Structural & Molecular Biology, 2005
- Defining a Pathway of Communication from the C-Terminal Peptide Binding Domain to the N-Terminal ATPase Domain in a AAA ProteinMolecular Cell, 2002